Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, tolerability, PK and PD of ZYIL1 in subjects with Cryopyrin Associated Periodic Syndromes (CAPS) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryopyrin-associated Periodic Syndrome

Drugs mentioned

• ZYIL1

Snippet

Sponsor: Zydus Lifesciences Limited | Conditions: Cryopyrin Associated Periodic Syndrome | Phase 2 | Status: COMPLETED